Frontiers in aging neuroscience · 2026
Corneal epithelial thickness can reflect the stage of Parkinson's disease and the severity of dry eye.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Dongyu, Ji Jiazheng, Zhang Xinyu, Yang Fan, Jin Xin, Wang Jingrao, Li Shumin, Yao Lifen, Zhang Hong
Аннотация
PURPOSE: To systematically analyze corneal epithelial thickness (CET) distribution in Parkinson's disease (PD) using anterior segment optical coherence tomography (AS-OCT) and investigate its correlation with disease stage and dry eye severity.
METHODS: This cross-sectional study enrolled 60 PD patients (120 eyes) and 29 age- and sex-matched healthy controls (58 eyes). The accessed parameters included dry eye disease (DED) metrics, such as the Ocular Surface Disease Index (OSDI), Schirmer I test (sIt), tear breakup time (BUT), corneal fluorescein staining (CFS), corneal sensitivity, and zonal CET measured by AS-OCT in central 2-mm, 5-mm, and 6-mm zones. Baseline PD characteristics included disease duration, levodopa equivalent daily dose (LEDD), Hoehn and Yahr (H-Y) stage, Movement Disorder Society Unified Parkinsond dPisease Rating Scale (MDS-UPDRS Part III), and Montreal Cognitive Assessment (MoCA).
RESULTS: PD patients showed significantly higher OSDI and CFS (p < 0.001), and lower sIt, BUT, and CET (p < 0.001). CET was significantly thinner in temporal, superior, and nasal quadrants of the 6-mm zone (p < 0.05). Temporal 6-mm CET was positively correlated with BUT (p = 0.024). With advancing H-Y stage, peripheral CET progressively thinned, while OSDI increased and BUT and sIt decreased, indicating worsening DED.
CONCLUSION: This study demonstrates, for the first time, that CET correlates with both dry eye severity and H-Y stage in PD. AS-OCT-based CET mapping may serve as a non-invasive biomarker for early neurodegeneration detection and guide ocular surface management.
METHODS: This cross-sectional study enrolled 60 PD patients (120 eyes) and 29 age- and sex-matched healthy controls (58 eyes). The accessed parameters included dry eye disease (DED) metrics, such as the Ocular Surface Disease Index (OSDI), Schirmer I test (sIt), tear breakup time (BUT), corneal fluorescein staining (CFS), corneal sensitivity, and zonal CET measured by AS-OCT in central 2-mm, 5-mm, and 6-mm zones. Baseline PD characteristics included disease duration, levodopa equivalent daily dose (LEDD), Hoehn and Yahr (H-Y) stage, Movement Disorder Society Unified Parkinsond dPisease Rating Scale (MDS-UPDRS Part III), and Montreal Cognitive Assessment (MoCA).
RESULTS: PD patients showed significantly higher OSDI and CFS (p < 0.001), and lower sIt, BUT, and CET (p < 0.001). CET was significantly thinner in temporal, superior, and nasal quadrants of the 6-mm zone (p < 0.05). Temporal 6-mm CET was positively correlated with BUT (p = 0.024). With advancing H-Y stage, peripheral CET progressively thinned, while OSDI increased and BUT and sIt decreased, indicating worsening DED.
CONCLUSION: This study demonstrates, for the first time, that CET correlates with both dry eye severity and H-Y stage in PD. AS-OCT-based CET mapping may serve as a non-invasive biomarker for early neurodegeneration detection and guide ocular surface management.